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This randomized controlled trial of a cognitive/behavioral integrated intervention during

33

pregnancy shows efficacy in reducing intimate partner violence victimization and

34

improving pregnancy outcomes.

PRÉCIS

2

35

ABSTRACT

36
37

OBJECTIVE: We estimated the efficacy of a psycho-behavioral intervention in reducing

38

intimate partner violence (IPV) recurrence during pregnancy and postpartum, and in improving

39

birth outcomes in African-American women

40

METHODS: We conducted a randomized controlled trial in which 1,044 women were recruited.

41

Individually-tailored counseling sessions were adapted from evidence-based interventions for

42

IPV and other risks. Logistic regression was used to model IPV victimization recurrence, to

43

predict minor, severe, physical and sexual IPV.

44

RESULTS: Women randomized to the intervention were less likely to have recurrent episodes

45

of IPV victimization (OR=0.48, 95%CI=0.29-0.80). Women with minor IPV were significantly

46

less likely to experience further episodes during pregnancy (OR=0.48, 95%CI=0.26-0.86,

47

OR=0.53, 95%CI=0.28-0.99) and postpartum (OR=0.56, 95%CI=0.34-0.93). Numbers needed to

48

treat were 17, 12, and 22, respectively as compared to the usual care Women with severe IPV

49

showed significantly reduced episodes at postpartum (OR=0.39, 95%CI=0.18-0.82) and number

50

needed to treat is 27. Women who experienced physical IPV showed significant reduction at the

51

first follow-up (OR=0.49, 95%CI=0.27-0.91) and postpartum (OR=0.47, 95%CI=0.27-0.82) and

52

number needed to treat is 18 and 20, respectively. Intervention women had significantly fewer

53

very preterm infants (p=0.03) and an increased mean gestational age (p=0.016).

54

CONCLUSION: A relatively brief intervention during pregnancy had discernable effects on IPV

55

and pregnancy outcomes. Screening for IPV as well as other psychosocial and behavioral risks

56

and incorporating similar interventions in prenatal care is strongly recommended.

57
58

Clinical Trial Registration: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00381823

59
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BACKGROUND

63

includes the threat or infliction of physical, sexual, or psychological abuse that is used by

64

perpetrators for the purpose of intimidation of and/or control over the victim.1-3 There is no set

65

agreement regarding what signs, symptoms or illnesses are considered the standard ICD-9

66

constellation for a diagnosis of IPV.4,5

67

Intimate partner violence (IPV) is defined as a pattern of assaultive and coercive behaviors, that

The CDC reports that approximately 5.4 million episodes of IPV occur every year in the

68

United States in women eighteen years and older. 6 The literature is inconsistent as to whether

69

minorities are at increased risk, with some studies reporting significant differences7-10 and others

70

finding no racial or ethnic differences.11,12 The most recent, largest and nationally

71

representative study found no differences of lifetime prevalence for IPV by race/ethnicity, while

72

the rate for the 12 months preceding the survey was almost twice as high among African-

73

Americans.13 Although some authors link IPV to socio-economically deprived communities, it is

74

by no means limited to the economically disadvantaged. Families with conflicting priorities and

75

stressors associated with limited psycho-social reserves may be at greatest risk.14 Factors

76

including housing conditions, poverty and street violence are associated with higher prevalence

77

of violence inside the home environment. Political disenfranchisement and cultural isolation may

78

also be mediators for IPV. Women living under such conditions are more likely to be victimized

79

as compared to women living in more stable and better organized communities.15-17

80

Exposure to IPV is associated with a range of negative psycho-behavioral risks as well as

81

health outcomes including increased risk of poor physical health, physical disability,

82

psychological distress, mental illness, and heightened substance use including alcohol and illicit

83

drugs.18 Sexual and physical IPV have been linked significantly with depression, suicidality, and

84

post traumatic stress disorder.19-22 Women who suffer from IPV are more likely to have
4

85

sexually transmitted diseases, vaginal bleeding or infection and urinary tract infections.23 Abuse

86

during pregnancy has been shown to be associated with significantly higher rates of depression,

87

suicide attempts as well as use of tobacco, alcohol and illicit drugs.24-31 IPV has been linked to

88

both pregnancy complications (e.g., inadequate weight gain, infections and bleeding) as well as

89

adverse pregnancy outcomes (low birth weight (LBW), preterm delivery (PTB) and neonatal

90

death).32-34 IPV amongst minority populations, already at higher risk for poor pregnancy

91

outcomes, may be a significant contributor to the health disparities observed in reproductive

92

outcomes amongst African-American women.

93

The objective of this paper is to estimate the efficacy of a cognitive behavioral

94

intervention administered as part of a randomized controlled trial (RCT) during prenatal care

95

(PNC) in reducing IPV recurrence during pregnancy and improving birth outcomes (LBW and

96

PTB) in a population of African-American residents of Washington, DC.

97

PARTICIPANTS AND METHODS

98

The “NIH-DC Initiative to Reduce Infant Mortality in Minority Populations” is a collaboration

99

between Children’s National Medical Center, Georgetown University, George Washington

100

University Medical Center, Howard University, the Eunice Kennedy Shriver National Institute of

101

Child Health and Human Development, the National Center on Minority Health and Health

102

Disparities and RTI International. As part of this collaboration, we conducted a RCT to evaluate

103

the efficacy of an integrated behavioral intervention delivered during PNC in reducing cigarette

104

smoking, environmental tobacco smoke exposure (ETSE), depression and IPV during pregnancy

105

and in improving pregnancy outcome. This study was reviewed and approved by the

106

institutional review boards of all participating institutions.

107

Women were screened at six community based PNC sites serving mainly minority

5

108

women in the District of Columbia between July, 2001 and October, 2003. Women were

109

demographically eligible if they self-identified as being a minority, were >18 years old, <28

110

weeks pregnant, a DC resident and English speaking. Almost two-thirds (63.4%) were recruited

111

before 22 weeks gestation, 16.9% were recruited between 22 and 25 weeks gestation and 19.7%

112

were recruited between 26 and 28 weeks gestation. The women who were demographically

113

eligible were consented in a two-stage consent and enrollment process. After initial consent,

114

participants were screened for the four risk factors (cigarette smoking, ETSE, depression, and

115

IPV) using an audio-computer assisted self interview which also confirmed their demographic

116

eligibility. An average of 9 days after screening, a baseline interview took place where more

117

detailed information on socio-demographics, reproductive history and behavioral risks was

118

collected. Following this interview, women were consented to participate.

119

collection by telephone interviews occurred during the second and third trimesters of pregnancy

120

(22-26 and 34-38 weeks gestation, respectively) and 8-10 weeks postpartum. Intervention and

121

follow-up activities continued until July 2004. Details are published in El-Khorazaty et al.35

122

A total of 2,913 women were screened and 1,398 met eligibility criteria (See Figure 1). Of these

123

85% (n=1,191) consented to participate in a baseline telephone interview before randomization;

124

1,070 (89.9%) were reached and participated. Eligible women were randomized to the

125

intervention group or usual care group. Of these women 1,044 were African-American and still

126

pregnant at the time of the baseline interview. Included in the analyses were 521 randomized to

127

the intervention and 523 randomized to usual care.

128

Follow-up data

Women randomized to the intervention received an integrated cognitive behavioral

129

intervention and women randomized to usual care received their usual prenatal care, as

130

determined by the standard procedures at the PNC clinic. 336 women reported IPV
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131

victimization in the past year during the baseline interview and this group could be further

132

categorized as having minor and/or severe IPV, physical and/or sexual IPV based on the Conflict

133

Tactics Scale (CTS).36 A woman may experience multiple types of violence; thus these

134

categories are not mutually exclusive. Minor IPV was defined if the woman’s partner slapped,

135

grabbed, pushed, or shoved her, threw something at her, twisted her arm or hair, and insisted,

136

without using force, on anal sex, intercourse, or sex without using a condom. Major IPV was

137

defined if the woman’s partner kicked, bit, punched, beat up, hit, choked or slammed her, used

138

knife or gun, burned or scalded her on purpose, and used force or threats to have sex or anal sex.

139

Physical IPV was defined if the woman’s partner threw something at her, pushed or shoved her,

140

used a knife or gun, hit, choked, slammed, grabbed, burned, or kicked her. Sexual assault was

141

defined if the woman’s partner forced sex without using a condom, forced her to have sex,

142

threatened or insisted on having sex (oral, anal, or vaginal) against her will.

143

The intervention utilized in this RCT was delivered during routine PNC visits at the

144

clinics by interventionists (master’s level social workers or psychologists), trained specifically to

145

deliver this intervention. The intervention was evidence-based and specific to each of the

146

designated psycho-behavioral risks.37 At each intervention session the woman identified which

147

of the four risks she was experiencing. The intervention was delivered by the interventionist and

148

targeted to address all risks reported at each session, regardless of previously reported risks. The

149

intervention for IPV emphasized safety behaviors and was based on the structured intervention

150

developed by Parker and colleagues38 and based on Dutton’s39 Empowerment Theory. This

151

intervention provided information about the types of abuse (e.g., emotional, physical and sexual)

152

and the cycle of violence (e.g., escalating, IPV, honeymoon period), a Danger Assessment

153

Component to assess risks, and preventive options women might consider (e.g., filing a
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154

protection order) as well as the development of a safety plan (e.g., leaving important documents

155

and papers with others). In addition, a list of community resources with addresses and phone

156

numbers was provided. The intervention for smoking and ETSE were combined and based on

157

Smoking Cessation or Reduction in Program Treatment. This intervention was cognitive-

158

behavioral and based on a woman’s stage of readiness for behavioral change.40 The depression

159

intervention was developed by Miranda and Munoz 41 based on cognitive behavioral theory and

160

focused on mood management, increasing pleasurable activities and increasing positive social

161

interactions.

162

The components of the intervention were designed for delivery in a minimum of four

163

sessions with eight prenatal sessions required for a complete intervention, based on the highest

164

number of sessions required for a specific risk. Fifty-one percent of the women randomized to

165

the intervention received four or more sessions, while one-quarter of the women attended no

166

intervention sessions. Individualized counseling sessions provided an integrated approach to

167

multiple risks responsive to a woman’s specific risk combination. Two additional postpartum

168

booster sessions were provided to reinforce risk-specific intervention goals and support women

169

through the postpartum period. Intervention sessions were conducted privately in a room

170

proximate to or within the PNC clinics and occurred immediately before or after routine PNC.

171

Intervention activities addressing all of the individually identified risks at each session lasted for

172

an average of 35+15 minutes. Women in the intervention received $10 for each intervention

173

session and additional $15 and $25 gift certificates for the first and second postpartum

174

intervention sessions, respectively.

175
176

During screening or follow-up, women reporting suicidal ideation were immediately
referred to the mental health consultation team. Women were evaluated and referred, as

8

177
178

necessary. Those found to be potentially suicidal (n=10) were excluded from the study.
The sample size was powered to test the reduction in psycho-behavioral risk, with the

179

theory that a reduction in risk would help improve pregnancy outcomes. Assuming a 5% level of

180

significance, 80% power would allow the detection of 10-20% reductions in risk-specific factors

181

among women in the intervention from a prevalence of 100% at recruitment. A sample of 1,050

182

women needed to be retained at the end of the follow-up period (525 women in each of the

183

intervention and usual care group). The anticipated number of women reporting IPV needed to

184

detect significance in reducing risk was 337 split between the two care groups). This sample size

185

was also sufficient to detect a 25% reduction in preterm birth and low birth weight combined in

186

the intervention as compared to that for the usual care group (estimated at 20%). Based on a

187

declining birth rate in D.C., the recruitment period was extended four months to reach the

188

required sample size.

189

Site- and risk-specific permuted block randomization to the intervention or usual care

190

was conducted. Both the investigators and the field workers were blinded to block size. A

191

computer generated randomization scheme was utilized to consider all the possible risk

192

combinations within each of the recruitment sites. When a woman completed the baseline

193

interview and was ready for randomization, the recruitment staff would call the data coordinating

194

center, where the subject’s assignment was determined.

195

Validated instruments were used for each of the data collection time points. During

196

screening, IPV was identified by the Abuse Assessment Screen, a measure designed and

197

validated for use in pregnancy if a woman reported physical or sexual abuse by a partner in the

198

previous year.42 During the baseline and follow-up interviews, the frequency of physical assault

9

199

and sexual coercion (partner to self) was measured by the Conflict Tactics Scale.36 A more

200

detailed description of instruments used for other risks is available in Katz et al.37

201

Telephone interviewers and their supervisors were blinded to the participants’

202

randomization group. Research staff maintained confidentiality when communicating with

203

participants outside the clinic setting. Addresses were collected to facilitate tracing efforts, but

204

the women were informed that they would not receive mail from Project DC-HOPE. For women

205

experiencing IPV, staff did not want to raise women’s risk for abuse by receiving mail from the

206

study that might be negatively regarded by an abusive partner, or would expose her pregnancy.

207

Women were also asked whether or not telephone messages from project staff could be left on

208

their telephone answering machines. If not, this was noted in her computerized record accessible

209

by all project teams. As financial incentives the women received $5 for the screening, a 30-

210

minute telephone card for providing main study consent, and $15 for each telephone interview.

211

At the time of recruitment medical records were abstracted and upon delivery data on infant and

212

pregnancy outcomes were recorded.

213

To preserve the randomization, participant data were analyzed according to their care

214

group assignment, regardless of receipt of intervention, using an intent-to-treat approach. All

215

statistical analyses were conducting using SAS version 9.1.3 (SAS Institute, Cary, NC).

216

Bivariate analyses were conducted to compare the baseline characteristics and pregnancy

217

outcomes of women assigned to the intervention versus usual care and to compare women who

218

reported a recurrence of IPV during pregnancy or postpartum versus those who did not. T-tests

219

compared groups based on continuous variables (using the TTEST procedure in SAS) and chi-

220

square tests compared the groups with respect to categorical variables (using SAS’s FREQ

221

procedure). Logistic regression was used to model recurrence of IPV based on care group
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222

assignment, controlling for relevant covariates (using the LOGISTIC procedure). Logistic

223

models were also created to predict minor, severe, physical and sexual IPV reported at each

224

interview. Adjusted odd ratios (AOR) were produced by models that included care group plus

225

other covariates.

226

RESULTS

227

Table 1 presents the sociodemographic characteristics and psycho-behavioral risks at baseline

228

between women randomized to the intervention (n=521) or usual care (n=523). There were no

229

significant differences between these two groups. During the baseline interview, 336 women

230

(32.2%) reported IPV in the previous year. Of these women 169 were in the intervention and

231

167 were in the usual care group (See Figure 1). In this subgroup, there were no significant

232

differences between the women in the two randomization groups (See Table 1). Mothers were of

233

24.5 years mean age. On average participants initiated PNC at 13 weeks of gestation. Seventy-

234

six percent were single, 68% had at least a high school education and 79% were enrolled in

235

Medicaid. In this population, 22% of the mothers admitted to active smoking during pregnancy,

236

78% self-identified as being at risk for ETSE and 62% were depressed as measured by the

237

Hopkins Scale. In addition, 32% admitted to using alcohol and 17% admitted to illicit drug use

238

during pregnancy.

239

Of those women reporting IPV at baseline, 306 women (91.1%) completed at least one of

240

the follow-up or postpartum interviews. No significant differences were found between those

241

with follow-up data (n=306) and those without (n=30), nor were women randomized to the

242

intervention (n=150) significantly different from those randomized to the usual care (n=156).

243

Women reporting continued IPV during pregnancy or postpartum (n=94) were

244

significantly different from those who reported no further episodes of IPV (n=212) beyond
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245

baseline with respect to care group (p=0.006), gestational age at baseline (p=0.035), alcohol use

246

during pregnancy (p=0.014) and depression at baseline (p=0.009).

247

Controlling for these four variables in the logistic regression, only care group, alcohol use

248

and depression were significant in the reduced model. Logistic regression results for continued

249

IPV at all interviews during pregnancy and postpartum (n=94) showed that women in the

250

intervention were less likely to have recurrent episodes of IPV (AOR=0.48, 95% CI=0.29-0.80).

251

Alcohol use during pregnancy measured at baseline and depression were associated with the

252

chance of recurrent episodes of IPV (AOR=1.85, 95% CI=1.09-3.12; AOR=1.90, 95% CI=1.11-

253

3.25, respectively). Women in the intervention were less likely to be victimized by their partners

254

at the first or second follow-up interviews (second or third trimester) (see Table 2). Although the

255

trend remains, the difference does not reach significance in the postpartum period.

256

Table 3 presents adjusted odds ratios and numbers needed to treat for the impact of the

257

intervention on minor IPV, severe IPV, physical IPV and sexual IPV at baseline and each of the

258

follow-up interviews. It should be noted that reported IPV at baseline refers to the one year

259

preceding the interview while at each of the three subsequent interviews, the reference period

260

was since the previous interview, on average 9-10 weeks during pregnancy and 14 weeks

261

between the second follow-up and the postpartum interview. At baseline no significant

262

differences between groups were observed for any of these four categories. Women with minor

263

IPV and randomized to the intervention were significantly less likely to experience further

264

episodes at all of the follow-up points. Women categorized with severe IPV in the intervention,

265

showed a significantly reduced incidence of episodes at postpartum, compared to the usual care

266

group. Women experiencing physical IPV were significantly less likely to experience episodes

267

at first follow-up or at postpartum interviews, compared to the usual care group. For women
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268

experiencing sexual IPV, the intervention did not significantly reduce their incidence of episodes

269

at any follow-up visit during pregnancy or postpartum.

270

For women experiencing IPV victimization throughout pregnancy and postpartum, Table

271

4 presents a comparison of intervention and usual care women with respect to various adverse

272

pregnancy outcomes. The results indicate that rates of low birthweight (<2,500 grams) (LBW)

273

were not different in the two groups (intervention=12.8% versus usual care=18.5%, p=0.204),

274

while very low birthweight (<1,500 grams) (VLBW) rates were lower among intervention

275

women (intervention=0.8% versus usual care=4.6%, p=0.052). In addition, rates of preterm

276

births (37 weeks gestation) (PTB) were not statistically different in the two groups (13.0% versus

277

19.7%, p=0.135). However, the two groups of women were significantly different with respect

278

to very PTB (<33 weeks gestation) (VPTB) (1.5% versus 6.6%, p=0.030). Also, for the mean

279

gestational age at delivery, the two groups were significantly different (38.2 weeks versus 36.9

280

weeks, p=0.016).

281

DISCUSSION

282

This study evaluates efficacy of a psycho-behavioral intervention during prenatal and postpartum

283

care on the reduction of IPV recurrence and improved pregnancy outcomes in African-American

284

mothers reporting IPV victimization. We were able to recruit 336 women acknowledging IPV

285

victimization within the past year during the baseline interview and who were willing to

286

participate in the intervention. In addition, 91% of these women continued to participate in this

287

randomized trial during pregnancy and/or postpartum. This finding emphasizes the relative ease

288

of recruitment of high risk African-American women to IPV reduction programs in the PNC

289

setting. The recruitment staff were trained to be culturally sensitive and the screening tool was

290

both simple and administered confidentially. These women are also willing to maintain
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291

participation in a program that provided cognitive behavioral strategies relevant to psycho-

292

behavioral problems they experienced during pregnancy.

293

The integrated intervention provided women with suggestions to deal with depression

294

and tobacco exposure in addition to strategies aimed at reducing risk of IPV. Alternative

295

explanations for our findings were considered. For other services for which we queried the

296

women, there were no differences between women experiencing IPV and those not. We also

297

considered whether women’s previous reproductive history might explain why the intervention

298

group had significantly better outcomes. None of the factors (previous preterm delivery,

299

previous miscarriage, previous stillbirth, number of previous voluntary interruptions of

300

pregnancy) that might predict poor reproductive outcomes were different between the two care

301

groups. Finally we considered whether medical conditions that might influence pregnancy

302

outcomes (preconception and gestational diabetes, chronic and gestational hypertension, or

303

sexually transmitted infections) were significantly different between the two care groups. None

304

of these medical conditions were significantly different between the two care groups.

305

The American College of Obstetricians and Gynecologists identifies the response to

306

domestic violence against women as a priority and recommends screening within primary care

307

settings.43 They also recommend the Patient Health Questionnaire as a screening instrument for

308

IPV, depression and anxiety. This questionnaire recognizes the co-occurrence of these psycho-

309

social risks as well as screening for substance exposure known to occur more frequently in

310

victims of IPV.24-27, 31 The findings of our study confirm the importance of emphasizing a more

311

global approach towards risk assessment and service provision to this population of high risk

312

African-American mothers.

313

IPV has been associated with poor pregnancy outcomes in the literature.28, 30, 32-34, 44-47
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314

Our study is the first we are aware of that found reductions in adverse pregnancy outcomes

315

despite previous evidence for associations between IPV during pregnancy and LBW.28, 30, 32-34

316

The intervention model targeting multiple risk factors in African-American women suffering

317

from IPV victimization shows promising results that could be translated toward reduction of

318

infant mortality within that population. The current literature agrees that very preterm infants

319

contribute more than 90% of the overall infant mortality statistic.48 The effect of the intervention

320

impacted multiple pregnancy outcomes, especially the highest level of neonatal risk, VLBW and

321

VPTB. The significant reduction of VLBW and VPTB in our intervention group may have

322

important implications on reduction of disparities in poor pregnancy outcomes and infant

323

mortality among African-Americans.

324

Whether or not our analyses were adjusted for alcohol use and depression, the

325

intervention universally reduced minor IPV during pregnancy and postpartum. It is important to

326

recognize that the classification of minor IPV on the Conflict Tactics Scale includes acts of

327

assault such as slapping, grabbing, pushing and shoving as well as twisting of the arm or hair.

328

While such actions may be considered minor on the CTS they are significant acts of aggression

329

and violence. The intervention was unable to impact more severe acts described as using a knife

330

or gun, choking, burning, scalding or kicking. The lack of effect on sexual IPV could be

331

attributed to the reluctance or discomfort of the study participants to divulge or discuss these

332

topics. The intervention team was instructed to show sensitivity to the level of comfort of the

333

study participants in this domain. The intervention as designed and implemented only reduced

334

the recurrence of minor and physical IPV, but could have reduced other associated risks.

335
336

The impact of IPV on pregnancy outcome is complicated by its co-occurrence with
depression and alcohol use.47,49-51 The behavioral intervention for depression could have
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337

significantly contributed to our success. Among the women reporting IPV at baseline, 62 percent

338

reported being depressed and 32 percent reported alcohol use during pregnancy. Addressing IPV

339

and depression together may have helped women implement suggested strategies to assess risks,

340

consider preventive options and develop a safety plan. We also detected a significant

341

association between IPV and illicit drug use (16.7%) and active smoking (22%), both known to

342

be risks for PTB and LBW.52,53 In reduced logistical models, alcohol use during pregnancy and

343

depression measured at baseline continued to exert a significant influence on perpetuating IPV

344

during pregnancy and postpartum. This describes a cycle where co-occurring risk factors are

345

immutably entangled.

346

A limitation of the study was that it was not powered to test the efficacy of the

347

intervention with respect to adverse pregnancy outcomes, but rather resolution of the psycho-

348

behavioral risks. Women were only modestly invested in participating in the intervention.

349

Despite the fact that we were able to deliver the minimum number of intervention sessions to

350

59% of participants with IPV, women randomized to the intervention were successful in risk

351

reduction. These rates of participation may be a reflection of difficult life circumstances among

352

poor urban women. These mothers encountered other behavioral challenges during pregnancy,

353

such as alcohol and drug use, that were not addressed by the intervention. Had we addressed

354

these, we might have been even more successful. The intervention effect(s) we found may apply

355

only to high risk minority pregnant women. It would be important to test this intervention in

356

other racial or sociodemographic groups to confirm generalizability. Larger studies testing the

357

effectiveness of implementing such interventions in community based clinics providing PNC

358

could have important health policy implications.

359

There is evidence that this intervention for pregnant African-American women reduced
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360

IPV victimization during pregnancy and improved pregnancy outcome. If generalizable, our

361

results should encourage health care providers and third party payers to go beyond screening for

362

psycho-social and behavioral risks to providing services during PNC to address such risks. The

363

potential cost savings associated with reduction of births within the highest risk category may be

364

substantial.

365
366
367
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Figure 1. Profile of Project DC-HOPE Randomized Controlled Trial

Screened for Eligibility
N = 2913

Eligible Women
N = 1398

Ineligible: N = 1515*
No Risk = 513
<18 years old = 22
>28 weeks EGA = 658
Not race eligible = 331
Not DC residents = 41
Not pregnant = 25
Participation Exclusion = 25
Suicidal = 2
Other Exclusion = 2
• More than one reason for
• ineligibility may apply.

Consented & No
Baseline Data: N = 121
Refused Interview = 17
Unable to Locate = 70
No longer pregnant. = 24
Other = 10

Consented, Completed
Baseline Interview
& Randomized: N = 1070
African-American
N = 1044

Data Available on IPV
Episodes: N = 150

Non African-American: N = 22
No Longer Pregnant: N = 4

Usual Care: N = 523

Intervention: N = 521

IPV at Baseline
N = 169

No consent: N = 207
Refused Consent = 165
Consent not Signed = 42

No IPV at Baseline
N = 352

IPV at Baseline
N = 167

No Data Available on IPV
Episodes: N = 19

Data Available on IPV
Episodes: N = 156
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No IPV at Baseline
N = 356
No Data Available on IPV
Episodes: N = 11

Table 1. Characteristics of All Participants and those Acknowledging Intimate Partner Violence
(IPV) Victimization at Baseline
All Participants
Characteristic

Value

Women with IPV at Baseline

Intervention
(N=521)

Usual Care
(N=523)

Intervention
(N=169)

Usual Care
(N=167)

Maternal age

Mean ± SD

24.4+5.5

24.8+5.3

24.5+5.8

24.5+5.4

Gestational age at enrollment (weeks)

Mean ± SD

19.3+6.9

18.6+6.8

19.2+6.8

18.5+6.9

Education level

< High school

159 (30.5%)

157 (30.0%)

54 (32.0%)

53 (31.7%)

HS graduate/GED

245 (47.0%)

241 (46.1%)

77(45.6%)

67 (40.1%)

At least some college

117 (22.5%)

125 (23.9%)

38 (22.5%)

47 (28.1%)

Working now

185 (35.5%)

196 (37.5%)

58 (34.3%)

67 (40.4%)

Not working now, worked
previous to pregnancy

185 (35.5%)

193 (36.9%)

67 (39.6%)

59 (35.5%)

Not working now, did not
work previous to pregnancy

150 (28.8%)

130 (24.9%)

44 (26.0%)

40 (24.1%)

Single/separated/widowed/
divorced

396 (76.0%)

401 (76.7%)

132 (78.1%)

122 (73.1%)

Married or living with
partner

125 (24.0%)

122 (23.3%)

37 (21.9%)

45 (27.0%)

Employment status

Relationship status

Emotional support from partner

Mean ± SD

36.9+20.6

37.3+20.5

32.8+20.9

32.7+19.7

Emotional support from others

Mean ± SD

39.4+15.1

40.8+14.7

37.7+14.9

39.3+14.9

Emotional support from partner prior
to delivery

Mean ± SD

34.3+21.6

33.9+21.8

31.0+21.9

29.6+21.6

Emotional support from others prior to
delivery

Mean ± SD

41.8+12.7

41.7+13.4

40.5+13.7

39.9+14.7

Trimester of PNC initiation

1st Trimester

305 (61.6%0

300 (58.9%)

94 (58.8%)

98 (60.9%)

2nd Trimester

179 (36.2%)

201 (39.5%)

60 (37.5%)

60 (37.3%)

3rd Trimester

11 (2.2%)

8 (1.6%)

6 (3.8%)

3 (1.9%)

Medicaid

Yes

411 (78.9%)

402 (76.8%)

134 (79.8%)

129 (77.7%)

WIC

Yes

226 (43.4%)

228 (43.6%)

74 (43.8%)

76 (45.5%)

Supplemental food program

Yes

369 (71.1%)

382 (73.0%)

168 (99.4%)

162 (97.0%)

Public assistance/TANF

Yes

213 (41.0%)

223 (42.7%)

73 (43.2%)

69 (41.3%)

Alcohol use in this pregnancy

Yes

111 (21.3%)

112 (21.4%)

58 (34.3%)

49 (29.3%)

Illicit drug use in this pregnancy

Yes

67 (12.9%)

56 (10.7%)

26 (15.4%)

30 (18.0%)

Marijuana use

Yes

62 (11.9%)

52 (9.9%)

23 (13.6%)

28 (16.8%)

Cocaine use

Yes

6 (1.2%)

7 (1.3%)

5 (3.0%)

3 (1.8%)

Pregnancy 'wanted'

Yes

403 (77.4%)

395 (75.5%)

127 (76.1%)

117 (71.3%)

Previous pregnancy

Yes

425 (81.6%)

443 (84.7%)

141 (83.4%)

144 (86.2%)

Previous live birth

Yes

173 (33.2%)

163 (31.2%)

112 (69.5%)

116 (69.5%)
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All Participants
Characteristic

Value

Women with IPV at Baseline

Intervention
(N=521)

Usual Care
(N=523)

Intervention
(N=169)

Usual Care
(N=167)

2.1+1.5

2.2+1.4

1.9+1.7

1.7+1.5

Number of live births (women with
previous pregnancy)

Mean ± SD

Previous preterm delivery

Yes

72 (14.2%)

66 (12.7%)

30 (22.2%)

23 (16.4%)

Previous stillbirth, miscarriage and
loss (women with previous pregnancy)

Yes

181 (42.6%)

192 (43.3%)

59 (42.1%)

68 (47.2%)

Gestational diabetes

Yes

25 (5.8%)

32 (7.0%)

8 (5.6%)

11 (7.5%)

Preconception diabetes

Yes

19 (3.7%)

18 (3.4%)

7 (4.2%)

4 (2.4%)

Gestational hypertension

Yes

14 (3.3%)

20 (4.4%)

3 (2.1%)

6 (4.1%)

Chronic hypertension

Yes

31 (6.0%)

29 (5.5%)

13 (7.8%)

5 (3.0%)

Active smoking at baseline

Yes

106 (20.3%)

92 (17.6%)

38 (22.5%)

36 (21.6%)

ETSE at baseline

Yes

365 (71.4%)

377 (73.3%)

128 (77.1%)

130 (78.8%)

Depression at baseline

Yes

229 (44.0%)

234 (44.7%)

101 (59.8%)

106 (63.5%)

IPV at baseline

Yes

169 (32.4%)

167 (31.9%)

---

---

Active smoking prior to delivery

Yes

70 (16.6%)

65 (15.2%)

24 (17.8%0

26 (19.6%)

ETSE prior to delivery

Yes

247 (58.7%)

277 (65.2%)

82 (61.2%)

89 (66.9%)

Depression prior to delivery

Yes

152 (35.9%)

170 (39.8%)

71 (52.6%)

71 (53.4%)

Active smoking at postpartum

Yes

89 (21.9%)

106 (25.0%)

31 (22..8%)

44 (31.9%)

ETSE at postpartum

Yes

196 (48.5%)

233 (55.9%)

63 ( 46.7%)

85 (63.0%)

Depression at postpartum

Yes

90 (22.2%)

118 (27.8%)

39 (28.9%)

51 (37.0%)

Notes: (1) PNC: prenatal care; WIC: Supplemental Nutrition Program for Women, Infant and Children; TANF: Temporary
Assistance for Needy Families; ETSE: Environmental Tobacco Smoke Exposure; IPV: Intimate Partner Violence
(2) All characteristics are measured at baseline except when noted otherwise.
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Table 2. Comparison of Intervention and Usual Care Groups by Continued IPV
Characteristic

Intervention

Usual Care

p-value

IPV Victim at FU1

14/92
(15.2%)

32/105
(30.5%)

0.012

IPV Victim at FU2

10/110
(9.1%)

20/110
(18.2%)

0.050

IPV Victim at PP

17/134
(12.7%)

29/137
(21.2%)

0.063

IPV Victim at All FU1, FU2 and
PP

35/150
(23.3%)

59/156
(37.8%)

0.006

Note: IPV: Intimate Partner Violence; U1: First Follow-up (22-26 weeks gestation) interview;
FU2: Second Follow-up (34-38 weeks gestation) interview; PP: Postpartum interview
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Table 3. Adjusted Odds Ratios* for the Impact of the Intervention on Various Categories of Intimate Partner Violence
Victimization during Pregnancy and Postpartum
Intervention vs. Usual Care
BL:
N (%)
AOR (95% CI)
Absolute Risk Difference**
Number Needed to Treat (95% CI)***
FU1:
N (%)
AOR (95% CI)
Absolute Risk Difference**
Number Needed to Treat (95% CI)***
FU2:
N (%)
AOR (95% CI)
Absolute Risk Difference**
Number Needed to Treat (95% CI)***
PP:
N (%)
AOR (95% CI)
Absolute Risk Difference**
Number Needed to Treat (95% CI)***

Minor IPV

Severe IPV

Physical IPV

Sexual IPV

327 (31.4%)
1.07 (0.81 – 1.40)
0.014
---

185 (17.7%)
0.97 (0.70 – 1.35)
0.004
---

295 (28.3%)
1.07 (0.81 – 1.42)
0.014
---

153 (14.7%)
1.03 (0.72 – 1.47)
0.004
---

56 (9.5%)
0.48 (0.26 – 0.86)
0.061
17 (11 – 67)

24 (4.1%)
0.53 (0.22 – 1.27)
0.024
---

52 (8.8%)
0.49 (0.27 – 0.91)
0.054
18 (12 – 108)

22 (3.7%)
0.39 (0.15 – 1.03)
0.031
---

49 (6.8%)
0.53 (0.28 – 0.99)
0.083
12 (5 – 642)

16 (2.2%)
0.85 (0.31 – 2.33)
0.004
---

34 (4.7%)
0.56 (0.27 – 1.17)
0.026
---

23 (3.2%)
0.55 (0.23 – 1.32)
0.018
---

72 (8.7%)
0.56 (0.34 – 0.93)
0.045
22 (14 – 146)

36 (4.4%)
0.39 (0.18 – 0.82)
0.037
27 (20 – 96)

62 (7.5%)
0.47 (0.27 – 0.82)
0.050
20 (14 – 61)

27 (3.3%)
0.99 (0.46 – 2.16)
0.001
---

Notes: IPV: Intimate Partner Violence; BL: Baseline; FU1: First Follow-up (22-26 weeks gestation); FU2: Second Follow-up (34-38 weeks
gestation); PP: Postpartum; AOR: Adjusted Odds Ratio; CI: Confidence Interval.
* Adjusted for alcohol use during pregnancy and depression at baseline.
** Absolute difference between intervention and usual care groups.
*** Number needed to treat is calculated for significant adjusted odds ratios and significant risk differences.
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Table 4. Pregnancy Outcomes among Women Experiencing Intimate Partner Violence
throughout Pregnancy and Postpartum by Care Group
Characteristic

Intervention
(n=150)

Usual Care
(n=156)

p-value

17 (12.8%)

24 (18.5%)

0.204

1 (0.8%)

6 (4.6%)

0.052

Birth Weight (grams): Mean + SD

3139 + 593

3098 + 717

0.618

PTB

18 (13.0%)

27 (19.7%)

0.135

VPTB

2 (1.5%)

9 (6.6%)

0.030

Gestational Age at Delivery (weeks) :
Mean + SD

38.2 + 3.3

36.9 + 5.9

0.016

LBW
VLBW

Note: LBW: Low Birth Weight; VLBW: Very Low Birth Weight; PTB: Preterm Birth;
VPTB: Very Preterm Birth; SD: Standard Deviation
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